Pharmacovigilance: new funds expected from AIFA’s Board of Directors
The new AIFA Board of Directors recently announced the allocation of funds for pharmacovigilance and cybersecurity.
AIFA reform: what is it and who are the new members of the governance
AIFA has recently embarked on a process of restructuring governance to promote investments in research and development and accelerate drug approval processes.
Clinical trials: Italian National Ethics Committees are operative now
The two Italian National Ethics Committees for clinical trials will evaluate the study protocols of their respective competencies on a monthly basis.
Drug shortages: the app for notifying patients is now available
Citizens can now always be updated on any shortages of medicines thanks to AIFA Medicinali.